Strategies for Pharmacists to Overcome Current Challenges and Integrate Novel Maintenance Therapies for the Management of COPD

Gain invaluable insights into updates in chronic obstructive pulmonary disease with this interactive text module, expert ClinicalThought commentary, and downloadable slideset. Faculty will highlight important updates in the 2024 GOLD Report, including new strategies for maintenance therapy, considerations on device selection, and emerging biologic therapies.

Share

Program Content

Activities

GOLD 2024 Report for COPD
A New GOLD Standard: Updates in Managing COPD
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 16, 2024

View Activity

Activities

Updates in COPD Management
Strategies for Pharmacists to Overcome Current Challenges and Integrate Novel Maintenance Therapies for the Management of COPD
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: January 29, 2024

Expires: January 28, 2025

View Activity

Activities

Novel Therapies for COPD
Strategies for Pharmacists to Overcome Current Challenges and Integrate Novel Maintenance Therapies for the Management of COPD
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 29, 2024

View Activity

Faculty

cover img faculity

J. Andrew Woods, PharmD, BCPS

Professor and Chair
Department of Translational Science and Inpatient Practice
Wingate University School of Pharmacy
Wingate, North Carolina

Provided by

ProCE Banner

Provided by ProCE, LLC

Supporters

This program is supported in part by an independent medical educational grant from Mylan Specialty L.P., a Viatris Company and Theravance Biopharma Inc.

Mylan Specialty L.P., a Viatris Company

Theravance Biopharma Inc.